{"id":"NCT03372161","sponsor":"Scilex Pharmaceuticals, Inc.","briefTitle":"Corticosteroid Lumbar Epidural Analgesia for Radiculopathy","officialTitle":"Corticosteroid Lumbar Epidural Analgesia for Radiculopathy (C.L.E.A.R.)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-12-08","primaryCompletion":"2021-08-20","completion":"2022-01-06","firstPosted":"2017-12-13","resultsPosted":"2022-09-19","lastUpdate":"2022-09-19"},"enrollment":401,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Lumbosacral Radicular Pain"],"interventions":[{"type":"DRUG","name":"SP-102","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"SP-102","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a research study of SP-102, an experimental medication designed to relieve pain in patients with a specific type of leg pain. The medication is given once by your healthcare professional, with a possibility of a second injection as early as about 1 month after the first treatment.\n\nThe purpose of the study is to measure how well a single injection of the experimental medication, SP-102, relieves pain. The study will also investigate the side effects of SP-102.","primaryOutcome":{"measure":"Mean Change From Baseline (Day 1) to Week 4 in the Mean Numeric Pain Rating Scale (NPRS) Average Pain Score in the Affected Leg","timeFrame":"Baseline, 4 Weeks","effectByArm":[{"arm":"SP-102","deltaMin":-2.34,"sd":1.842},{"arm":"Placebo","deltaMin":-1.16,"sd":1.723}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":37,"countries":["United States"]},"refs":{"pmids":["38875121"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":202},"commonTop":["Headache","Upper respiratory tract infection","Urinary tract infection","Hypertension","Nausea"]}}